GSK PLC-SPON ADR (GSK) Stock Analyst Earnings Estimates
NYSE:GSK - New York Stock Exchange, Inc. - US37733W2044 - ADR
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 24.696B 1.40% | 29.324B 18.74% | 30.328B 3.42% | 32.088B 5.80% | 33.272B 3.69% | 35.086B 5.45% | 36.961B 5.34% | 37.065B 0.28% | 37.132B 0.18% | 38.124B 2.67% | 36.75B -3.60% | 44.839B 22.01% | |
| EBITDA YoY % growth | 8.126B -2.62% | 10.542B 29.73% | 10.598B 0.53% | 10.502B -0.91% | 11.54B 9.88% | 12.525B 8.54% | 13.215B 5.51% | 13.239B 0.18% | 13.293B 0.41% | 13.633B 2.56% | 11.35B -16.75% | 12.675B 11.67% | |
| EBIT YoY % growth | 5.749B -4.09% | 8.395B 46.03% | 8.304B -1.08% | 8.699B 4.76% | 9.665B 11.10% | 10.732B 11.04% | 11.97B 11.54% | 12.116B 1.22% | 11.899B -1.79% | 11.492B -3.42% | 8.839B -23.09% | N/A | |
| Operating Margin | 23.28% | 28.63% | 27.38% | 27.11% | 29.05% | 30.59% | 32.39% | 32.69% | 32.05% | 30.14% | 24.05% | N/A | |
| EPS YoY % growth | 2.86 -1.99% | 2.99 4.54% | 3.13 4.85% | 3.21 2.32% | 3.54 10.29% | 3.94 11.42% | 4.19 6.44% | 4.24 1.19% | 4.13 -2.59% | 4.26 3.10% | 3.79 -11.12% | 4.48 18.20% |
All data in GBP
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.41 -28.96% | 0.95 9.45% | 0.97 10.36% | 1.03 2.17% | 0.63 52.51% |
| Revenue Q2Q % growth | 7.943B -1.35% | 7.813B 6.11% | 8.286B 5.10% | 8.637B 7.80% | 8.642B 8.80% |
| EBITDA Q2Q % growth | 1.782B -53.68% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 1.443B 44.59% | 2.647B 17.80% | 2.679B 15.47% | 2.873B 11.57% | 1.926B 33.47% |
All data in GBP
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 1.00 -1.39% | 0.91 | 0.10 | 10.89% |
| Q2 2024 Q2Q % growth | 0.88 11.86% | 0.79 | 0.09 | 11.14% |
| Q1 2024 Q2Q % growth | 0.87 16.49% | 0.76 | 0.11 | 14.88% |
| Q4 2023 Q2Q % growth | 0.58 12.02% | 0.60 | -0.01 | -1.98% |
| Q3 2023 Q2Q % growth | 1.02 7.46% | 0.96 | 0.05 | 5.56% |
| Q2 2023 Q2Q % growth | 0.78 12.14% | 0.73 | 0.05 | 7.52% |
| Q1 2023 Q2Q % growth | 0.75 -8.92% | 0.69 | 0.06 | 8.62% |
| Q4 2022 Q2Q % growth | 0.52 -19.37% | 0.46 | 0.06 | 13.62% |
| Q3 2022 Q2Q % growth | 0.95 2.51% | 0.83 | 0.12 | 14.45% |
| Q2 2022 Q2Q % growth | 0.70 -1.49% | 0.60 | 0.10 | 16.49% |
| Q1 2022 Q2Q % growth | 0.82 41.92% | 0.78 | 0.04 | 4.62% |
| Q4 2021 Q2Q % growth | 0.65 9.87% | 0.64 | 0.01 | 1.36% |
| Q3 2021 Q2Q % growth | 0.92 2.81% | 0.75 | 0.17 | 22.51% |
| Q2 2021 Q2Q % growth | 0.71 46.35% | 0.52 | 0.19 | 35.82% |
| Q1 2021 Q2Q % growth | 0.58 -38.77% | 0.56 | 0.02 | 3.70% |
| Q4 2020 Q2Q % growth | 0.59 -6.05% | 0.61 | -0.02 | -2.81% |
| Q3 2020 Q2Q % growth | 0.90 -7.77% | 0.79 | 0.10 | 13.09% |
| Q2 2020 Q2Q % growth | 0.48 -37.05% | 0.53 | -0.04 | -8.23% |
| Q1 2020 Q2Q % growth | 0.94 24.25% | 0.80 | 0.15 | 18.15% |
| Q4 2019 Q2Q % growth | 0.63 | 0.66 | -0.03 | -4.59% |
| Q3 2019 Q2Q % growth | 0.97 | 0.87 | 0.11 | 12.42% |
| Q2 2019 Q2Q % growth | 0.77 | 0.65 | 0.12 | 17.97% |
| Q1 2019 Q2Q % growth | 0.76 | 0.66 | 0.10 | 15.31% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 8.012B -1.66% | 8.298B | -286M | -3.45% |
| Q2 2024 Q2Q % growth | 7.884B 9.84% | 7.695B | 189M | 2.46% |
| Q1 2024 Q2Q % growth | 7.363B 5.93% | 7.279B | 84M | 1.15% |
| Q4 2023 Q2Q % growth | 8.052B 9.16% | 7.513B | 539M | 7.17% |
| Q3 2023 Q2Q % growth | 8.147B 4.06% | 7.964B | 183M | 2.30% |
| Q2 2023 Q2Q % growth | 7.178B 3.59% | 7.032B | 146M | 2.08% |
| Q1 2023 Q2Q % growth | 6.951B -3.32% | 6.634B | 317M | 4.78% |
| Q4 2022 Q2Q % growth | 7.376B 4.24% | 7.563B | -187M | -2.47% |
| Q3 2022 Q2Q % growth | 7.829B 18.14% | 7.555B | 274M | 3.63% |
| Q2 2022 Q2Q % growth | 6.929B 18.69% | 6.702B | 227M | 3.39% |
| Q1 2022 Q2Q % growth | 7.19B -3.07% | 9.265B | -2.075B | -22.40% |
| Q4 2021 Q2Q % growth | 7.076B -19.03% | 9.782B | -2.706B | -27.66% |
| Q3 2021 Q2Q % growth | 6.627B -23.35% | 8.986B | -2.359B | -26.25% |
| Q2 2021 Q2Q % growth | 5.838B -23.43% | 7.785B | -1.947B | -25.01% |
| Q1 2021 Q2Q % growth | 7.418B -18.39% | 8.12B | -702M | -8.65% |
| Q4 2020 Q2Q % growth | 8.739B -1.80% | 9.001B | -262M | -2.91% |
| Q3 2020 Q2Q % growth | 8.646B -7.87% | 9.034B | -388M | -4.29% |
| Q2 2020 Q2Q % growth | 7.624B -2.37% | 7.953B | -329M | -4.14% |
| Q1 2020 Q2Q % growth | 9.09B 18.65% | 8.949B | 141M | 1.58% |
| Q4 2019 Q2Q % growth | 8.899B | 9.29B | -391M | -4.21% |
| Q3 2019 Q2Q % growth | 9.385B | 9.326B | 59M | 0.63% |
| Q2 2019 Q2Q % growth | 7.809B | 7.805B | 4M | 0.05% |
| Q1 2019 Q2Q % growth | 7.661B | 7.776B | -115M | -1.48% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -0.04% | -6.78% | -0.04% | -3.55% |
| Revenue | 0% | -3.04% | -0.66% | -1.49% |